Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Non-Current Assets (2016 - 2025)

Utah Medical Products has reported Non-Current Assets over the past 16 years, most recently at $24.8 million for Q4 2025.

  • Quarterly results put Non-Current Assets at $24.8 million for Q4 2025, down 5.37% from a year ago — trailing twelve months through Dec 2025 was $102.8 million (down 6.76% YoY), and the annual figure for FY2025 was $24.8 million, down 5.37%.
  • Non-Current Assets for Q4 2025 was $24.8 million at Utah Medical Products, down from $25.4 million in the prior quarter.
  • Over the last five years, Non-Current Assets for UTMD hit a ceiling of $47.8 million in Q1 2021 and a floor of $24.8 million in Q4 2025.
  • Median Non-Current Assets over the past 5 years was $30.5 million (2023), compared with a mean of $33.1 million.
  • Biggest five-year swings in Non-Current Assets: dropped 22.17% in 2022 and later dropped 4.62% in 2024.
  • Utah Medical Products' Non-Current Assets stood at $42.5 million in 2021, then fell by 20.06% to $34.0 million in 2022, then dropped by 14.04% to $29.2 million in 2023, then fell by 10.21% to $26.2 million in 2024, then decreased by 5.37% to $24.8 million in 2025.
  • The last three reported values for Non-Current Assets were $24.8 million (Q4 2025), $25.4 million (Q3 2025), and $26.4 million (Q2 2025) per Business Quant data.